The Effect of Propolis in Tinea Pedis Treatment: A Randomized Controlled Study

NCT04789083 | Completed DMC

• 1 other identifier: NecmettinErbakanU-Burucu
• Study Type: interventional
• Target: 96
• Locations: 1 country
• Sites: 1

Brief Summary

Tineapedis is an important health problem. Providing foot care in tinea pedis treatment contributes positively to the treatment. In addition, alternative treatments can also be used. In this study, the randomization study group will be divided into three. Medical treatment and foot care training will be applied to the first group, medical treatment and propolis to the second group, medical treatment and plassebo to the control group. Foot care training will be given by nurse coaching. Times of all three groups and their response to treatment will be evaluated.

Conditions

Nurse's Role; Patient Education; Foot Care

Keywords

nursing; nurse coaching; patient education; complementary therapy; althernative therapy

Outcome Measures

Primary Outcomes (1)

• Evaluation

  Dermatological Quality of Life Scale

  3 month

Secondary Outcomes (1)

• Doctor's an patient's global

  3 month

Study Arms (3)

Group 1 (Propolis)

EXPERIMENTAL

Medical therapy and propolis

Other: Propholis extrate

Group 2 (Nurse Coaching/ Nursing education)

EXPERIMENTAL

Medical treatment and nurse coaching

Other: Propholis extrate

Group 3 (Plassebo)

PLACEBO COMPARATOR

Medical treatment and plassebo will be applied.

Other: Propholis extrate

Interventions

Propholis extrate OTHER

Plassebo

Also known as: Nurse coaching/ Nursing education

Group 1 (Propolis); Group 2 (Nurse Coaching/ Nursing education); Group 3 (Plassebo)

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Not being pregnant
• Not being breastfeeding
• Not having confusion
• Not being immunosuppressed
• Not using systemic cortisone
• Not having any dermatological problems (psoriasis, contact dermatitis, etc.) that will affect the treatment.
• Agree to participate in research
• Being accessible by phone
• Having no problems communicating by phone
• Not having problems with physical care

You may not qualify if:

• Pregnant / nursing women
• Using systemic antifungal therapy
• Using systemic croticosteroids
• In the process of treatment for oncological reasons
• Are using immunosuppressants
• Dermatological disease (contact dermatitis, psoriasis)
• Under the age of 18 and over the age of 64
• Have cognitive problems
• There is no telephone / telephone number within reach
• Individuals who have difficulties in speaking and understanding Turkish will be excluded from the study.

Sponsors & Collaborators

• Necmettin Erbakan University: lead

Study Sites (1)

Necmettin Erbakan Univercity

Konya, 42370, Turkey (Türkiye)

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assit. Prof.

Model Details: This study is a double blind randomized controlled study

Study Record Dates

• First Submitted: December 10, 2020
• First Posted: March 9, 2021
• Study Start: February 3, 2022
• Primary Completion: August 19, 2022
• Study Completion: August 30, 2022
• Last Updated: February 2, 2023

Record last verified: 2023-02

Locations

TU (1)